Login / Signup

When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?

Romain Samuel RothStavroula Masouridi-LevratFederica GiannottiAnne-Claire MamezSarah MorinChristian van DeldenYves ChalandonDionysios Neofytos
Published in: Mycoses (2022)
Long treatment courses are observed in patients with IMI, due to prolonged immunosuppression. Although immune reconstitution and radiological response were frequently observed at EOT, consistent documentation of treatment discontinuation based on well-defined parameters is lacking.
Keyphrases
  • bone marrow
  • low dose
  • mesenchymal stem cells
  • high dose
  • candida albicans
  • replacement therapy